Marnie LaVigne
President & CEO @ Launch NY
Buffalo, United States
Marnie LaVigne is a convertible note investor at Launch NY in Buffalo focused on Software and Health Care. Marnie LaVigne has spent more than 25 years in both the private and public sectors creating new products and start-up businesses, driving innovation and economic growth in high-tech industries, such as life sciences, informatics, and advanced manufacturing. Her passion for working with start-ups took root from her experience launching healthinformatics businesses with colleagues in the 1990’s as she finished her doctoral work at the University of Rochester, which resulted in growing two different firms with more than 100 employees and two initial public offerings (IPOs).In July, 2014, she became the President and CEO of Launch NY, a 27-county venture development organization that she co-founded with other Buffalo boosters and whose mission is to identify, support and invest in high-growth, high-impact companies and catalyze the entrepreneurial culture of Upstate New York. Previously, she led economic development efforts involving work with hundreds of firms at UB as Associate Vice President for Economic Development from 2012 to 2014 and Director of Business Development from 2005 until 2012 at the NYS Center of Excellence in Bioinformatics & Life Sciences and the UB Center for Advanced Biomedical and Bioengineering Technology. In addition to her for profit start-up experience prior to UB, Marnie also served in lead product development positions in larger corporations in managed care (e.g., Aetna), pharmaceuticals (Bristol-Myers Squibb), medical devices (Welch Allyn), and medical informatics (Medscape/MedicaLogic, now GE and WebMD).Marnie has a bachelor's degree in neuroscience and a doctorate in clinical psychology, both from the University of Rochester. She is an editorial board member for Disease Management, and a member of the Board of Directors for Buffalo Angels, Insyte Consulting, New York State Economic Development Council, Niagara Falls Memorial Medical Center, and Western New York Venture Association.
- Total investments:
- 115
- Last investment:
- Lead investor:
- 51%
Last updated:
For AI agents: llms.txt
Industries Marnie LaVigne invests in
Stages Marnie LaVigne invests in
Countries Marnie LaVigne invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 16 (14%)
- Health Care 12 (10%)
- Manufacturing 7 (6%)
- Internet 6 (5%)
- Food and Beverage 6 (5%)
Stage
- Convertible Note 40 (35%)
- Seed 34 (30%)
- Venture - Series Unknown 5 (4%)
- Pre-Seed 3 (3%)
- Series A 3 (3%)
Country
- United States 61 (53%)
- Canada 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Ognomy Sleep provides virtual sleep apnea care services that connect patients with sleep medicine specialists through telehealth appointments, home-based sleep testing, and ongoing treatment support. The company offers a digital care platform designed to help diagnose and manage sleep apnea through consultations, at-home evaluations, andpersonalized therapy options. Ognomy Sleep supports treatments such as PAP therapy, oral appliance therapy, Inspire implant therapy, and weight management options related to sleep apnea care. The platform also works with healthcare providers through referral services that support patient coordination and follow-up care. | $20M / Series A / Jun 30, 2026 | ||
| Nudge Money is an AI financial guidance platform leveraging behavioral economics and financial planning to infuse timely and personalized advice into automated marketing channels at community financial institutions and fintechs, increasing conversion 7x while building loyalty. | $500K / Seed / Aug 22, 2024 | ||
| CareTech Human offers an automated solution for continuous health monitoring and disease prevention. They provide a toilet-integrated solution for daily health checks and early disease detection. | $175K / Seed / May 29, 2024 | ||
| Edenesque produces plant-based milk, non-dairy products using natural ingredients like almonds, cashew, and hemp, and customized cold-pressed juices, catering to dietary preferences. | $175K / Venture - Series Unknown / Apr 23, 2024 | ||
| TeleSafety is a mobile app that provides real-time access to workplace safety experts by helping with important questions or professional advice. | Seed / Jan 30, 2024 | ||
| AvantGuard creats innovative solutions that manage surfaces and provide long-term protection against viruses, bacteria, and fungi/mold, in a variety of applications. | $2.9M / Seed / May 11, 2023 | ||
| Jeca Bar makes vegan-friendly, holistic energy bars to fuel its customers' busy lives. They are made with all-natural, plant-based superfoods and healthful ingredients. No preservatives, no artificial additives, no compromises. Just wholesome, convenient, nutrition for home, the office, or on the go. | $100K / Seed / Sep 07, 2022 | ||
| Bringing music education into the future. | Seed / Jun 20, 2022 | ||
| Feedback Solutions is a company that provides ventilation optimization solution using ingenious sensor technology. | Seed / May 31, 2022 | ||
| Arbol is launching an insurance marketplace that connects weather exposed agricultural entities with capital providers like insurers and asset managers. Arbol’s parametric insurance platform removes information asymmetry and reduces administrative costs by leveraging objective data from satellites and weather stations. | Convertible Note / May 31, 2022 | ||
| See all 115 investments → | |||
Co-Investors
About Launch NY
Launch NY is a U.S. Treasury-designated Community Financial Institution (CDFI) and a 501(c)(3) nonprofit venture development organization, providing pro bono mentoring and capital access to high-growth potential startups across Upstate NY. The mission is to identify, support and invest in high-growth, high-impact companies, and catalyze theentrepreneurial culture in the 27 counties comprising the western half of Upstate New York.
Launch NY Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Al Culliton
Entrepreneur in Residence
|
|||
|
Marnie LaVigne
President & CEO
|
|||
David Thiemecke
Entrepreneur In Residence
|
|||
Ed Bizari
Entrepreneur In Residence
|
|||
Kate Brodock
Entrepreneur In Residence
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Marnie LaVigne invest in?
Marnie LaVigne invests primarily in Software, Health Care and Manufacturing startups, most often at Convertible Note and Seed stage. Most of the 115 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Marnie LaVigne?
Public channels for Marnie LaVigne include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Marnie LaVigne last invest?
The most recent investment recorded for Marnie LaVigne closed in Jun 2026. Shizune tracks 115 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
